Today’s Stock Market in 2-Minutes
April 17, 2026
-
-
Vaxart Announces Share Purchase Agreement for up to $25 Million with Lincoln Park Capital
April 17, 2026
-
ProStar Launches TracksAI, An AI Driven Real-Time Analytics, Performance, and Quality Control Reporting Module
April 17, 2026
-
Odysight.ai Signs Commercial Collaboration Agreement with GACI Technologies to Expand AI-Powered Predictive Maintenance into the French Aerospace and Defense Market
April 17, 2026
-
Top News
- iAnthus Expands Florida Footprint with new Dispensary Presence in Jupiter, FL April 17, 2026
- Mountain Valley MD Announces Appointment of Advisors and Stock Option Grants April 17, 2026
- Western Asset Diversified Income Fund (NYSE: WDI) Announces Portfolio Management Team Update April 17, 2026
- Soluna Acquires Full Ownership of Project Dorothy 1A, Accelerating Vertical Integration and AI Campus Development April 16, 2026
Sequire Spotlight Presents: Gevo (GEVO) – Drop-In Jet Fuel From Renewables Poised for Scale
Patrick Gruber, CEO of Gevo (NASDAQ: GEVO), shares how the company is pioneering renewable, drop-in hydrocarbon jet fuels that are cost-competitive with traditional petroleum-based alternatives. With over 450 patents and projects backed by a $1.63B DOE loan guarantee, Gevo is scaling commercial production through facilities in South Dakota and North Dakota. The company’s ethanol-based jet fuel, carbon capture, and RNG assets are unlocking significant revenue streams—positioning Gevo to become EBITDA positive in 2025. With $270M+ in cash, strategic partnerships, and bipartisan support for 45Z tax credits, Gevo is accelerating the transition to net-zero aviation fuels.
May 22, 2025Popular Reads
-
Biofrontera Inc.: A Dermatology Company Scaling with Momentum
April 8, 2026
-
Oncotelic Therapeutics Reports FY 2025 Results Highlighting $249M Net Income and JV Pipeline Progress
AGOURA HILLS, Calif., April 16, 2026 (GLOBE NEWSWIRE) — Oncotelic Therapeutics, Inc. (OTCQB:OTLC) (“Oncotelic”, the “Company” or “We”), a clinical-stage biopharmaceutical company developing drugs for the treatment of orphan oncology indications, as well as antisense and small molecule injectable drugs for the treatment of cancer, today announced its financial results for the fiscal year ended December 31, […]
April 16, 2026
-
Is This Next Gold Discovery Brewing? (MMET:CSE | MMETF:OTCQX)
April 14, 2026
-
Next-Generation Defense Is Unmanned as Global Drone Industry Targets $160Billion+ Expansion
Military adoption leads the charge as drones become essential tools across intelligence, protection, and combat missions Market News Updates News Commentary NEW YORK, April 16, 2026 /PRNewswire/ — Counter-Drones have quickly gone from ‘nice-to-have’ tools to absolute must-haves for modern militaries. Today’s armed forces rely on them for surveillance, targeting, logistics support, and even direct strike missions—all […]
April 16, 2026
News
-
Today’s Stock Market in 2-Minutes
April 17, 2026
-
Vaxart Announces Share Purchase Agreement for up to $25 Million with Lincoln Park Capital
April 17, 2026
-
ProStar Launches TracksAI, An AI Driven Real-Time Analytics, Performance, and Quality Control Reporting Module
April 17, 2026
-
Odysight.ai Signs Commercial Collaboration Agreement with GACI Technologies to Expand AI-Powered Predictive Maintenance into the French Aerospace and Defense Market
April 17, 2026
-
Mountain Valley MD Announces Appointment of Advisors and Stock Option Grants
April 17, 2026
-
Western Asset Diversified Income Fund (NYSE: WDI) Announces Portfolio Management Team Update
April 17, 2026
-
iAnthus Expands Florida Footprint with new Dispensary Presence in Jupiter, FL
April 17, 2026
-
Today’s Stock Market in 2-Minutes
April 16, 2026